Detalhe da pesquisa
1.
Trial of Cinpanemab in Early Parkinson's Disease.
N Engl J Med
; 387(5): 408-420, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921450
2.
Digital Mobility Measures: A Window into Real-World Severity and Progression of Parkinson's Disease.
Mov Disord
; 39(2): 328-338, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38151859
3.
Validity of the Short Weekly Calendar Planning Activity in patients with Parkinson disease and nonmanifesting LRRK2 and GBA carriers.
Eur J Neurol
; : e16327, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38743695
4.
Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
Mov Disord
; 37(1): 190-195, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34550621
5.
Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker.
Mov Disord
; 36(7): 1592-1602, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33751655
6.
Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning.
Mov Disord
; 36(9): 2144-2155, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33955603
7.
Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trial.
BMC Neurol
; 21(1): 459, 2021 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34814867
8.
A Possible Modifying Effect of the G2019S Mutation in the LRRK2 Gene on GBA Parkinson's Disease.
Mov Disord
; 35(7): 1249-1253, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32353202
9.
Tossing and Turning in Bed: Nocturnal Movements in Parkinson's Disease.
Mov Disord
; 35(6): 959-968, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32080891
10.
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.
Mov Disord
; 35(11): 1999-2008, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32798333
11.
Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models.
Neurobiol Dis
; 124: 276-288, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30381260
12.
Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
Mol Genet Metab
; 128(4): 470-475, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31662221
13.
Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054.
Mov Disord
; 34(8): 1154-1163, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31211448
14.
Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic.
Mov Disord
; 33(5): 684-696, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29704272
15.
Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or Severity.
Mov Disord
; 37(3): 651-652, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064687
16.
Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).
Alzheimers Dement
; 11(7): 840-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26194317
17.
The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age.
Mov Disord
; 34(5): 676-681, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30901492
18.
Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's disease.
Parkinsonism Relat Disord
; 123: 106970, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38691978
19.
Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical Trial.
Neurology
; 102(5): e209137, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38315945
20.
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials.
Amyotroph Lateral Scler Frontotemporal Degener
; 25(3-4): 382-387, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38396337